(Nano) platforms in bladder cancer therapy: Challenges and opportunities
M Ashrafizadeh, A Zarrabi… - Bioengineering & …, 2023 - Wiley Online Library
Urological cancers are among the most common malignancies around the world. In
particular, bladder cancer severely threatens human health due to its aggressive and …
particular, bladder cancer severely threatens human health due to its aggressive and …
[HTML][HTML] Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling
M Entezari, M Ghanbarirad, A Taheriazam… - Biomedicine & …, 2022 - Elsevier
Among the different kinds of tumors threatening human life, lung cancer is one that is
commonly observed in both males and females. The aggressive behavior of lung cancer …
commonly observed in both males and females. The aggressive behavior of lung cancer …
Nanotechnological approaches in prostate cancer therapy: integration of engineering and biology
Nanocarriers have received special attention in biomedicine for the treatment of various
diseases, especially cancer, as one of the leading causes of death worldwide. Nanocarriers …
diseases, especially cancer, as one of the leading causes of death worldwide. Nanocarriers …
NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition
Metastasis of tumor cells is a complex challenge and significantly diminishes the overall
survival and prognosis of cancer patients. The epithelial‐to‐mesenchymal transition (EMT) …
survival and prognosis of cancer patients. The epithelial‐to‐mesenchymal transition (EMT) …
Long noncoding RNAs (lncRNAs) in pancreatic cancer progression
M Ashrafizadeh, N Rabiee, AP Kumar, G Sethi… - Drug Discovery …, 2022 - Elsevier
Long noncoding RNAs (lncRNAs) are RNA molecules involved in gene regulation at
transcriptional, post-transcriptional, and epigenetic levels. LncRNAs participate in regulating …
transcriptional, post-transcriptional, and epigenetic levels. LncRNAs participate in regulating …
Non-coding RNAs and macrophage interaction in tumor progression
M Entezari, M Sadrkhanloo, M Rashidi, SE Asnaf… - Critical reviews in …, 2022 - Elsevier
The macrophages are abundantly found in TME and their M2 polarization is in favor of tumor
malignancy. On the other hand, non-coding RNAs (ncRNAs) can modulate macrophage …
malignancy. On the other hand, non-coding RNAs (ncRNAs) can modulate macrophage …
Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects
M Hashemi, S Mirzaei, M Barati, ES Hejazi… - Life sciences, 2022 - Elsevier
Urological cancers include bladder, prostate and renal cancers that can cause death in
males and females. Patients with urological cancers are mainly diagnosed at an advanced …
males and females. Patients with urological cancers are mainly diagnosed at an advanced …
[HTML][HTML] Regulated cell death in urinary malignancies
Z Nie, M Chen, Y Gao, D Huang, H Cao… - Frontiers in Cell and …, 2021 - frontiersin.org
Urinary malignancies refer to a series of malignant tumors that occur in the urinary system
and mainly include kidney, bladder, and prostate cancers. Although local or systemic …
and mainly include kidney, bladder, and prostate cancers. Although local or systemic …
Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: mechanisms of initiation, progression, and drug sensitivity
The identification of agents that can reverse drug resistance in cancer chemotherapy, and
enhance the overall efficacy is of great interest. Paclitaxel (PTX) belongs to taxane family …
enhance the overall efficacy is of great interest. Paclitaxel (PTX) belongs to taxane family …
[HTML][HTML] Long noncoding RNA LINC02470 sponges MicroRNA-143-3p and enhances SMAD3-mediated epithelial-to-mesenchymal transition to promote the …
CS Huang, CH Tsai, CP Yu, YS Wu, MF Yee, JY Ho… - Cancers, 2022 - mdpi.com
Simple Summary Long noncoding RNAs (lncRNAs) were proposed as novel tumor
prognostic markers, including for predicting bladder cancer progression, and the competing …
prognostic markers, including for predicting bladder cancer progression, and the competing …